ArticleIJU case reports2019
Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade.
Tomoya Hatayama, Yohei Sekino, Hiroyuki Shikuma, Sakurako Mukai, Masayuki Muto, Shunsuke Miyamoto, Kosuke Sadahide, Kenichiro Fukuoka, Shinsuke Fuji, Keisuke Goto and 9 more
Open access · goldAbstract readCase Reports
In one paragraphArticle in IJU case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors at 2 institutions in 1 country.
Tomoya HatayamaDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Sakurako MukaiDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Masayuki MutoDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Shunsuke MiyamotoDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Kosuke SadahideDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Kenichiro FukuokaDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Shinsuke FujiDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Keisuke GotoDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Shunsuke ShinmeiDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Keisuke HiedaDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Shogo InoueDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Tetsutaro HayashiDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Jun TeishimaDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Naoto KurodaDepartment of Diagnostic Pathology Kochi Red Cross Hospital Kochi Japan.
Kazuhiro SentaniDepartment of Molecular Pathology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Wataru YasuiDepartment of Molecular Pathology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Akio MatsubaraDepartment of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Hiroshima University · JPJapanese Red Cross Kochi Hospital · JP
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
introductionRenal mucinous tubular and spindle cell carcinoma is a rare subtype of renal cell carcinoma newly added to the World Health Organization classification in 2004. Although it has been considered as a tumor with good prognosis, aggressive cases have recently been reported. CASE PRESENTATION: A 52-year-old man was diagnosed as having left renal cell carcinoma. Open radical left nephrectomy and left-sided pelvic lymph nodes dissection were performed. Pathological diagnosis revealed a renal mucinous tubular and spindle cell carcinoma with high nuclear grade and extra-regional lymph nodes metastasis classified as pT3aN0M1. After nephrectomy, metastasis at second lumbar vertebra and lymph nodes recurrence were occurred.
conclusionThis tumor with high nuclear grade may be potentially aggressive and carries a poor prognosis.
Indexed as
high nuclear graderenal cell carcinomarenal mucinous tubular and spindle cell carcinoma
Identifiers
PMID32743410
PMCPMC7292185
OpenAlexW2944228177
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390